Glaucoma surgery is a rapidly evolving therapy that has demonstrated substantial benefit yet has fallen short of offering an effective means for the management of all glaucoma patients. Our proprietary Calibreye™ Titratable Glaucoma Therapyä (TGT) Surgical System aims to provide next-generation IOP management, safety without sacrificing efficacy, a familiar delivery technique, and the ability to […]
ECS12 – MistGo® Company website: www.web.com MistGo® is an innovative alternative to the conventional eye drop bottle, designed to help patients administer their eye medication in a more precise and user-friendly way. A better user experience translates into higher patient compliance, healthier eyes, and higher quality of life for patients. Nagel1,* 1Denmark Technical University, Copenhagen, […]
ECS08 – Simulation of multifocal corrections in the clinic Company website: www.web.com Simulation of multifocal corrections in the clinic Marcos1,2,* 1University of Rochester, Rochester, United States, 2CSIC, Madrid, Spain PROBLEM & UNMET NEED Presbyopia is a non-preventable, gradual, and irreversible eye condition characterized by the loss of the ability to focus on near objects. It […]
Aura Biosciences, Inc. is a clinical-stage biotechnology company headquartered in Boston, Massachusetts. The company is focused on developing precision therapies for solid tumors with the aim of preserving organ function. Aura’s proprietary platform utilizes Virus-Like Drug Conjugates (VDCs), which are engineered to deliver targeted treatments to cancer cells while minimizing damage to surrounding healthy tissue. […]
ECS09 – CustomLens Ai Company website: www.web.com CustomLens Ai: Personalising Vision, Scaling Precision Pande1,* 1Ophthalmology, Vision Surgery & Research Centre, North Ferriby , United Kingdom CustomLens.ai is a cloud-based comprehensive lens surgery expert system designed to automatically generate complete surgical prescriptions inclusing intraocular lens (IOL) selection and surgical planning through explainable AI. CustomLens Ai is proud […]
Multispectral Refraction Topography, called MRT, which is the world’s FIRST peripheral refraction detection device, enables the personalized management of myopia to be practical and effective. While technological advancements have revolutionized modern lifestyles, they have also intensified a global vision crisis—myopia, affecting billions worldwide, particularly acute in China. A key driver of this epidemic, peripheral hyperopic […]
Compex s.r.o., an ophthalmic device start-up headquartered in Brno (Czech Republic), has developed Jett Medical, the first MDR-approved therapy for Meibomian Gland Dysfunction (MGD) based on direct-current (DC) stimulation. Unmet Clinical Need Meibomian Gland dysunction (MGD) is main cause of dry eye diseases and accounts for over 70 % of all dry-eye disease. No pharmaceutical […]
Stuart Therapeutics, a development stage pharmaceutical company based in the United States, has recently completed its first Phase 3 trial of ST-100 (Vezocolmitide), a novel topical therapeutic for the treatment of dry eye disease. ST-100 is based on the Company’s patented Polycol™ platform, a large set of collagen mimetic peptides (CMPs) recognized as a new […]
Epion Therapeutics (Epion) is developing EpiSmart™, a minimally-invasive treatment for keratoconus and ectatic corneal disease that could bring early intervention to millions of patients globally. EpiSmart’s true epithelium-on approach – without chemical or physical disruption of the epithelium – is designed to reduce patient discomfort and significantly reduce recovery time versus current standards of care. […]
Tearful is a medical diagnostics company focused on transforming Dry Eye Disease (DED) evaluation through i-Onion™ device the worlds first patented device for assessing the maximal secretion capacity of the lacrimal gland. Our technology the i-Onion™ is a portable, easy-to-use diagnostic tool that uses a gentle CO2 puff to stimulate reflex tear production. This allows […]
